Bookmarks
Medicines in Acute and Chronic Care
Description
{"type":"doc","content":[{"type":"paragraph","content":[{"type":"text","text":"The Medicines in Acute and Chronic Care Driver programme aims to understand and transform the use of medicines for patients of all ages, especially those with complex care needs caused by multiple long-term conditions. "}]},{"type":"paragraph","content":[{"type":"text","text":"Medicines are fundamental in maintaining human health. However, adverse drug reactions are increasingly common, especially as the world’s population ages. There is also an unacceptably high rate of medicines related errors, fuelled by the complexity of guidelines and the expanding array of potential therapies. "}]},{"type":"paragraph","content":[{"type":"text","text":"The Medicines in Acute and Chronic Care Programme will tackle the most critical health challenges associated with medicines, in the UK and oversees."}]}]}
MuMPreDiCT (Pregnancy and postpartum outcomes of mothers and their offspring)
Dataset population size: Unknown
Health and disease
Hospital Electronic Prescribing and Medicines Administration System (HEPMA)
Dataset population size: Unknown
Health and disease
Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care
Dataset population size: 5,917,115
Health and disease
Environmental determinants of health; linked health and DEFRA air quality data
Dataset population size: 1,914,540
Health and disease, Measurements/Tests
Pharmacogenetics at scale in real-world bioresources: CYP2C19 and clopidogrel outcomes in UK Biobank.
Bedair KF, Smith B, Palmer CNA, Doney ASF, Pearson ER.
2024